| [1] |
Zollo JD, Zeitouni NC. The Roswell Park Cancer Institute experience with extramammary Paget's disease[J]. Br J Dermatol, 2000, 142(1):59-65.
|
| [2] |
Parker LP, Parker JR, Bodurka-Bevers D, et al. Paget's disease of the vulva: pathology, pattern of involvement, and prognosis[J]. Gynecol Oncol, 2000, 77(1):183-189.
|
| [3] |
Tebes S, Cardosi R, Hoffman M. Paget's disease of the vulva[J]. Am J Obstet Gynecol, 2002, 187(2):281-283.
|
| [4] |
Sawada Y, Bito T, Kabashima R, et al. Ectopic extramammary Paget's disease: case report and literature review[J]. Acta Derm Venereol, 2010, 90(5):502-505.
|
| [5] |
Scarbrough CA, Vrable A, Carr DR. Definition, association with malignancy, biologic behavior, and treatment of ectopic extramammary Paget's disease: a review of the literature[J]. J Clin Aesthet Dermatol, 2019, 12(8): 40-44.
|
| [6] |
Goldblum JR, Hart WR. Vulvar Paget's disease: a clinicopathologic and immunohistochemical study of 19 cases[J]. Am J Surg Pathol, 1997, 21(10): 1178-1187.
|
| [7] |
Goldblum JR, Hart WR. Perianal Paget's disease: a histologic and immunohistochemical study of 11 cases with and without associated rectal adenocarcinoma[J]. Am J Surg Pathol, 1998, 22(2):170-179.
|
| [8] |
Nowak MA, Guerriere-Kovach P, Pathan A, et al. Perianal Paget's disease: distinguishing primary and secondary lesions using immunohistochemical studies including gross cystic disease fluid protein-15 and cytokeratin 20 expression[J]. Arch Pathol Lab Med, 1998, 122(12):1077-1081.
|
| [9] |
Kanitakis J. Mammary and extramammary Paget's disease[J]. J Eur Acad Dermatol Venereol, 2007, 21(5):581-590.
|
| [10] |
Shepherd V, Davidson EJ, Davies-Humphreys J. Extramammary Paget's disease[J]. BJOG, 2005, 112(3):273-279.
|
| [11] |
Hatta N, Yamada M, Hirano T, et al. Extramammary Paget's disease: treatment, prognostic factors and outcome in 76 patients[J]. Br J Dermatol, 2008, 158(2):313-318.
|
| [12] |
Fujisawa Y, Yoshino K, Kiyohara Y, et al. The role of sentinel lymph node biopsy in the management of invasive extramammary Paget's disease: multi-center, retrospective study of 151 patients[J]. J Dermatol Sci, 2015, 79(1):38-42.
|
| [13] |
狄金明.机器人辅助右巨大肾癌根治+腔静脉癌栓取出术[J/OL].中华腔镜泌尿外科杂志(电子版), 2023, 17(3):310-311.
|
| [14] |
Ito T, Kaku-Ito Y, Furue M. The diagnosis and management of extramammary Paget's disease[J]. Expert Rev Anticancer Ther, 2018, 18(6):543-553.
|
| [15] |
Farasat S, Yu SS, Neel VA, et al. A new American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: creation and rationale for inclusion of tumor (T) characteristics[J]. J Am Acad Dermatol, 2011, 64(6):1051-1059.
|
| [16] |
Ito T, Kaku Y, Nagae K, et al. Tumor thickness as a prognostic factor in extramammary Paget's disease[J]. J Dermatol, 2015, 42: 269-275.
|
| [17] |
Dai B, Kong YY, Chang K, et al. Primary invasive carcinoma associated with penoscrotal extramammary Paget's disease: a clinicopathological analysis of 56 cases[J]. BJU Int, 2015, 115(1):153-160.
|
| [18] |
Ohara K, Fujisawa Y, Yoshino K, et al. A proposal for a TNM staging system for extramammary Paget disease: retrospective analysis of 301 patients with invasive primary tumors[J]. J Dermatol Sci, 2016, 83(3):234-239.
|
| [19] |
Ishizuki S, Nakamura Y. Extramammary Paget's disease: diagnosis, pathogenesis, and treatment with focus on recent developments[J]. Curr Oncol, 2021,28(4):2969-2986.
|
| [20] |
Oji M, Furue M, Tamaki K. Serum carcinoembryonic antigen level in Paget's disease[J]. Br J Dermatol, 1984, 110(2):211-213.
|
| [21] |
Kato J, Sumikawa Y, Hida T, et al. Serum cytokeratin 19 fragment 21-1 is a useful tumor marker for the assessment of extramammary Paget's disease[J]. J Dermatol, 2017, 44(6): 666-670.
|